Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Director · Co-CEO and CFO | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 1,757,850 |
Ending reported balance
After 2026-09-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-24 · Grant · Acquired 177,858 · Balance 1,856,206 F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29. 2025. Row 2 · 2026-09-24 · Tax withholding · Disposed 98,356 · Balance 1,757,850 F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29. 2025.
F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 25, 2026 20:12 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 98,356 | $5.27 | $518,336.12 |
DisclosureSEC source: 0001628280-26-063576 · wk-form4_1790367134.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,757,850 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| September 24, 2026 Filed Sep 25, 2026 20:12 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 177,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-063576 · wk-form4_1790367134.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,856,206 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29. 2025. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:25 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 31,671 | $5.31 | $168,173.01 |
DisclosureSEC source: 0001628280-26-061362 · wk-form4_1789071952.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,678,348 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 199,209 | $5.09 | $1,013,973.81 |
DisclosureSEC source: 0001628280-26-051814 · wk-form4_1785787573.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,710,019 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 179,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051814 · wk-form4_1785787573.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,909,228 F2 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 181,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051814 · wk-form4_1785787573.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730,068 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 31,671 | $5.87 | $185,908.77 |
DisclosureSEC source: 0001628280-26-042183 · wk-form4_1781121979.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,548,997 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 08, 2026 Filed Jun 18, 2026 20:10 UTC Amendment | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 31,671 | $5.87 | $185,908.77 |
DisclosureSEC source: 0001628280-26-044283 · wk-form4a_1781813433.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,548,997 F1 · kind: On June 10, 2026, the reporting person filed a Form 4 (the "Original Form") which inadvertently used the "S" code in Column 3 of Table I in connection with the disposal of certain shares of the Issuer's Class A common stock (the "Shares") on June 8, 2026. The Shares were in fact withheld by the Issuer to satisfy tax withholding obligations in connection a vesting event in a transaction approved in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Footnote 1 to the Original Form correctly described the transaction as "shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units." Accordingly, the reporting person is hereby amending the Original Form to correctly show the "F" code in Column 3 of Table I. The information set forth in the Original Form was correct in all other respects. F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 21:45 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 301,731 | $4.92 | $1,484,516.52 |
DisclosureSEC source: 0001628280-26-027654 · wk-form4_1777326352.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,580,668 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:45 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 545,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-027654 · wk-form4_1777326352.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,882,399 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 21:28 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 31,314 | $4.54 | $142,165.56 |
DisclosureSEC source: 0001628280-26-016559 · wk-form4_1773178123.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,336,774 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 35,348 | $4.38 | $154,824.24 |
DisclosureSEC source: 0001628280-25-056755 · wk-form4_1765573564.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,368,088 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 21:15 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | PurchaseClass A common stock, $0.0001 par value per share | 17,000 | $4.47 | $76,044.40 |
DisclosureSEC source: 0001628280-25-056310 · wk-form4_1765401309.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,403,436 F1 · kind: The reporting person realized short-swing profits under Section 16(b) of the Exchange Act as a result of transactions reported on this Form 4. On December 10, 2025, the reporting person disgorged to the Issuer the Section 16(b) short-swing profits realized by the reporting person from such transactions. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:52 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 100,133 | $5.03 | $503,668.99 |
DisclosureSEC source: 0001628280-25-049658 · wk-form4_1762379525.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386,436 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| October 31, 2025 Filed Nov 5, 2025 21:52 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 181,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-049658 · wk-form4_1762379525.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486,569 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 21:07 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 35,348 | $4.00 | $141,392.00 |
DisclosureSEC source: 0001779128-25-000109 · wk-form4_1757711251.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Director · Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305,497 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 46,918 | $4.94 | $231,821.84 |
DisclosureSEC source: 0001779128-25-000075 · wk-form4_1754432066.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,340,845 F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.94 to $4.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 76,177 | $3.99 | $303,946.23 |
DisclosureSEC source: 0001779128-25-000075 · wk-form4_1754432066.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,387,763 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 139,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000075 · wk-form4_1754432066.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,463,940 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 35,348 | $3.80 | $134,322.40 |
DisclosureSEC source: 0001779128-25-000049 · wk-form4_1749676861.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,324,654 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 100,000 | $4.07 | $406,590.00 |
DisclosureSEC source: 0001779128-25-000049 · wk-form4_1749676861.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,360,002 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.96 to $4.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 35,679 | $3.12 | $111,318.48 |
DisclosureSEC source: 0001779128-25-000019 · wk-form4_1742243008.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,460,002 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 124,396 | $3.12 | $388,115.52 |
DisclosureSEC source: 0001779128-25-000019 · wk-form4_1742243008.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,495,681 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 222,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000019 · wk-form4_1742243008.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,620,077 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| January 08, 2025 Filed Jan 8, 2025 21:38 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000002 · wk-form4_1736372305.xml · derivative · entry 4 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 175,000 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 8, 2025 21:38 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 175,000 | $0.18 | $31,500.00 |
DisclosureSEC source: 0001779128-25-000002 · wk-form4_1736372305.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,397,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 21:38 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 900 | $5.00 | $4,502.97 |
DisclosureSEC source: 0001779128-25-000002 · wk-form4_1736372305.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,222,220 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:38 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 103,670 | $5.02 | $520,516.70 |
DisclosureSEC source: 0001779128-25-000002 · wk-form4_1736372305.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,223,120 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 25,312 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-24-000161 · wk-form4_1734988987.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Class A common stock, $0.0001 par value per share · 25,312 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 25,312 | $0.18 | $4,556.16 |
DisclosureSEC source: 0001779128-24-000161 · wk-form4_1734988987.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,326,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2024 Filed Dec 11, 2024 22:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 35,348 | $4.72 | $166,842.56 |
DisclosureSEC source: 0001779128-24-000151 · wk-form4_1733956627.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,301,478 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 22:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 39,285 | $5.02 | $197,018.20 |
DisclosureSEC source: 0001779128-24-000151 · wk-form4_1733956627.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,336,826 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 23:01 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 23,815 | $5.02 | $119,627.51 |
DisclosureSEC source: 0001779128-24-000138 · wk-form4_1733266878.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,376,111 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 20:24 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 24,688 | $0.18 Strike: $0.18 | $4,443.84 |
DisclosureSEC source: 0001779128-24-000134 · wk-form4_1732047876.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,312 Underlying: Class A common stock, $0.0001 par value per share · 24,688 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 20:24 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 24,688 | $0.18 | $4,443.84 |
DisclosureSEC source: 0001779128-24-000134 · wk-form4_1732047876.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,399,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 16:05 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 35,348 | $2.85 | $100,741.80 |
DisclosureSEC source: 0001779128-24-000119 · wk-form4_1726243497.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,375,238 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 14, 2024 Filed Aug 15, 2024 16:11 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.18 Strike: $0.18 | $4,500.00 |
DisclosureSEC source: 0001779128-24-000111 · wk-form4_1723738262.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Class A common stock, $0.0001 par value per share · 25,000 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2024 Filed Aug 15, 2024 16:11 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 25,000 | $0.18 | $4,500.00 |
DisclosureSEC source: 0001779128-24-000111 · wk-form4_1723738262.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,410,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 57,994 | $2.94 | $170,502.36 |
DisclosureSEC source: 0001779128-24-000085 · wk-form4_1718659309.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,385,586 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.18 Strike: $0.18 | $5,400.00 |
DisclosureSEC source: 0001779128-24-000078 · wk-form4_1718228572.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Class A common stock, $0.0001 par value per share · 30,000 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 30,000 | $0.18 | $5,400.00 |
DisclosureSEC source: 0001779128-24-000078 · wk-form4_1718228572.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,443,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 20,552 | $3.28 | $67,365.35 |
DisclosureSEC source: 0001779128-24-000052 · wk-form4_1712348761.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404,468 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.175 to $3.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 03, 2024 Filed Apr 17, 2024 21:24 UTC Amendment | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 11,440 | $3.28 | $37,498.03 |
DisclosureSEC source: 0001779128-24-000056 · wk-form4a_1713389042.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,413,580 F1 · shares: The original Form 4, filed on April 5, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on April 3, 2024 as a total of 20,552 shares sold when in fact only 11,440 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 9,112 shares. F2 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.175 to $3.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F1 · balance_after: The original Form 4, filed on April 5, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on April 3, 2024 as a total of 20,552 shares sold when in fact only 11,440 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 9,112 shares. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 18:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.18 Strike: $0.18 | $8,100.00 |
DisclosureSEC source: 0001779128-24-000044 · wk-form4_1710959719.xml · derivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,000 Underlying: Class A common stock, $0.0001 par value per share · 45,000 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 18:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 45,000 | $0.18 | $8,100.00 |
DisclosureSEC source: 0001779128-24-000044 · wk-form4_1710959719.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,425,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:36 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.18 Strike: $0.18 | $4,500.00 |
DisclosureSEC source: 0001779128-24-000034 · wk-form4_1710538590.xml · derivative · entry 4 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,000 Underlying: Class A common stock, $0.0001 par value per share · 25,000 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:36 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 25,000 | $0.18 | $4,500.00 |
DisclosureSEC source: 0001779128-24-000034 · wk-form4_1710538590.xml · nonDerivative · entry 3 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,380,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:36 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 26,632 | $2.62 | $69,898.35 |
DisclosureSEC source: 0001779128-24-000034 · wk-form4_1710538590.xml · nonDerivative · entry 2 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,355,020 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:36 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 27,210 | $2.76 | $75,232.93 |
DisclosureSEC source: 0001779128-24-000034 · wk-form4_1710538590.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,381,652 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.655 to $2.875, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 22:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 20,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-24-000025 · wk-form4_1710280933.xml · nonDerivative · entry 1 Heyburn William A. · CIK 0001859732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,408,862 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. All of the RSUs will vest on April 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.